The DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.
Study of matrix metalloproteinases and their inhibitors in breast cancer
Open accessAbstract
An immunohistochemical study was performed using tissue microarrays and specific antibodies against matrix metalloproteinases (MMPs) 1, 2, 7, 9, 11, 13, 14, and their tisullar inhibitors (TIMPs) 1, 2, and 3. More than 2600 determinations on cancer specimens from 131 patients with primary ductal invasive tumours of the breast (65 with and 66 without distant metastasis) and controls were performed. Staining results were categorised using a score based on the intensity of the staining and a specific software program calculated the percentage of immunostained cells automatically. We observed a broad variation of the total immunostaining scores and the cell type expressing each protein. There were multiple and significant associations between the expression of the different MMPs and TIMPs evaluated and some parameters indicative of tumour aggressiveness, such as large tumour size, advanced tumour grade, high Nottinham prognostic index, negative oestrogen receptor status, peritumoural inflammation, desmoplastic reaction, and infiltrating tumoural edge. Likewise, the detection of elevated immunohistochemical scores for MMP-9, 11, TIMP-1, and TIMP-2, was significantly associated with a higher rate of distant metastases. The expression of MMP-9 or TIMP-2 by tumour cells, MMP-1, 7, 9, 11, 13, or TIMP-3 by fibroblastic cells, and MMP-7, 9, 11, 13, 14, TIMP-1, or TIMP-2 by mononuclear inflammatory cells, was also significantly associated with a higher rate of distant metastases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cluster analysis and display of genome-wide expression patterns
Eisen, M. B., Spellman, P. T., Brown, P. O., & Botstein, D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.14863 · Cited by 16,184
New functions for the matrix metalloproteinases in cancer progression
Egeblad, M., & Werb, Z. (2002) · Nature Reviews Cancer · doi:10.1038/nrc745 · Cited by 6,108
Tissue microarrays for high-throughput molecular profiling of tumor specimens
Kononen, J., Bubendorf, L., Kallionimeni, A., Bärlund, M., Schraml, P., Leighton, S., Torhorst, J., Mihatsch, M. J., Sauter, G., & Kallionimeni, O.-P. (1998) · Nature Medicine · doi:10.1038/nm0798-844 · Cited by 4,099
A multigenic program mediating breast cancer metastasis to bone
Kang, Y., Siegel, P. M., Shu, W., Drobnjak, M., Kakonen, S. M., Cordón-Cardo, C., Guise, T. A., & Massagué, J. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00132-6 · Cited by 2,597
The microenvironment of the tumour–host interface
Liotta, L. A., & Kohn, E. C. (2001) · Nature · doi:10.1038/35077241 · Cited by 2,310
Mechanism Of Cell Surface Activation Of 72-kDa Type IV Collagenase
Strongin, A. Y., Collier, I., Bannikov, G., Marmer, B. L., Grant, G. A., & Goldberg, G. I. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.10.5331 · Cited by 1,593
Matrix Metalloproteinases: Biologic Activity and Clinical Implications
Nelson, A. R., Fingleton, B., Rothenberg, M. L., & Matrisian, L. M. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.5.1135 · Cited by 1,554
Strategies for MMP inhibition in cancer: innovations for the post-trial era
Overall, C. M., & López-Otín, C. (2002) · Nature Reviews Cancer · doi:10.1038/nrc884 · Cited by 1,349
A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas
Basset, P., Bellocq, J. P., Wolf, C., Stoll, I., Hutin, P., Limacher, J. M., Podhajcer, O. L., Chenard, M. P., Rio, M. C., & Chambon, P. (1990) · Nature · doi:10.1038/348699a0 · Cited by 1,131
The Nottingham prognostic index in primary breast cancer
Galea, M. H., Blamey, R. W., Elston, C. E., & Ellis, I. O. (1992) · Breast Cancer Research and Treatment · doi:10.1007/bf01840834 · Cited by 1,070
Stromal Effects on Mammary Gland Development and Breast Cancer
Wiseman, B. S., & Werb, Z. (2002) · Science · doi:10.1126/science.1067431 · Cited by 923
Biochemical Characterization of Human Collagenase-3
Knäuper, V., López-Otin, C., Smith, B., Knight, G., & Murphy, G. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.3.1544 · Cited by 881
Matrix metalloproteinases in angiogenesis: a moving target for therapeutic intervention
Stetler-Stevenson, W. G. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6870 · Cited by 842
Validation of Tissue Microarray Technology in Breast Carcinoma
Camp, R. L., Charette, L. A., & Rimm, D. L. (2000) · Laboratory Investigation · doi:10.1038/labinvest.3780204 · Cited by 799
Freije, J. M., Díez-Itza, I., Balbín, M., Sánchez, L. M., Blasco, R., Tolivia, J., & López-Otín, C. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)89457-7 · Cited by 762
Release of an invasion promoter E-cadherin fragment by matrilysin and stromelysin-1
Noë, V., Fingleton, B., Jacobs, K., Crawford, H. C., Vermeulen, S., Steelant, W., Bruyneel, E., Matrisian, L. M., & Mareel, M. (2001) · Journal of Cell Science · doi:10.1242/jcs.114.1.111 · Cited by 695
Osteoblasts in prostate cancer metastasis to bone
Logothetis, C. J., & Lin, S.-H. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1528 · Cited by 614
Sakr, W. A., Grignon, D. J., Crissman, J. D., Heilbrun, L. K., Cassin, B. J., Pontes, J. J., & Haas, G. P. (1994) · PubMed · Cited by 575
Complex roles of tissue inhibitors of metalloproteinases in cancer
Jiang, Y., Goldberg, I. D., & Shi, Y. E. (2002) · Oncogene · doi:10.1038/sj.onc.1205291 · Cited by 507
Matrix Metalloproteinases Generate Angiostatin: Effects on Neovascularization
Cornelius, L. A., Nehring, L. C., Harding, E., Bolanowski, M., Welgus, H. G., Kobayashi, D. K., Pierce, R. A., & Shapiro, S. D. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.12.6845 · Cited by 444
Queen, M. M., Ryan, R. E., Holzer, R. G., Keller-Peck, C. R., & Jorcyk, C. L. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1734 · Cited by 413
MMP-7 promotes prostate cancer-induced osteolysis via the solubilization of RANKL
Lynch, C. C., Hikosaka, A., Acuff, H. B., Martin, M. D., Kawai, N., Singh, R. K., Vargo-Gogola, T. C., Begtrup, J. L., Peterson, T. E., Fingleton, B., et al. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.04.013 · Cited by 393
Wnt 5a signaling is critical for macrophage-induced invasion of breast cancer cell lines
Pukrop, T., Klemm, F., Hagemann, T., Gradl, D., Schulz, M., Siemes, S., Trümper, L., & Binder, C. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509703103 · Cited by 363
Knäuper, V., Cowell, S., Smith, B., López-Otin, C., O'Shea, M., Morris, H., Zardi, L., & Murphy, G. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.12.7608 · Cited by 350
High-grade prostatic intraepithelial neoplasia
Bostwick, D. G., & Qian, J. (2004) · Modern Pathology · doi:10.1038/modpathol.3800053 · Cited by 345
Interstitial collagenases as markers of tumor progression.
Brinckerhoff, C., Rutter, J. L., & Benbow, U. (2000) · PubMed · Cited by 339
Pellikainen, J. M., Ropponen, K. M., Kataja, V. V., Kellokoski, J. K., Eskelinen, M. J., & Kosma, V.-M. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1061 · Cited by 339
Ahonen, M., Baker, A. H., & Kähäri, V. (1998) · PubMed · Cited by 266
Tumor Vesicle—Associated CD147 Modulates the Angiogenic Capability of Endothelial Cells
Millimaggi, D., Mari, M., D'Ascenzo, S., Carosa, E., Jannini, E. A., Zucker, S., Carta, G., Pavan, A., & Dolo, V. (2007) · Neoplasia · doi:10.1593/neo.07133 · Cited by 237
Proteases, Extracellular Matrix, and Cancer
DeClerck, Y. A., Mercurio, A. M., Stack, M. S., Chapman, H. A., Zutter, M. M., Muschel, R. J., Raz, A., Matrisian, L. M., Sloane, B. F., Noel, A., et al. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63200-2 · Cited by 232
Chantrain, C. F., Shimada, H., Jodele, S., Groshen, S., Ye, W., Shalinsky, D. R., Werb, Z., Coussens, L. M., & DeClerck, Y. A. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-0160 · Cited by 218
Matrix metalloproteinase-2 immunoreactive protein: A marker of aggressiveness in breast carcinoma
Talvensaari-Mattila, A., P��kk�, P., H�yhty�, M., Blanco-Sequeiros, G., & Turpeenniemi-Hujanen, T. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19980915)83:6<1153::aid-cncr14>3.0.co;2-4 · Cited by 217
Matrix metalloproteinase-2 (MMP-2) is associated with survival in breast carcinoma
Talvensaari-Mattila, A., Pääkkö, P., & Turpeenniemi-Hujanen, T. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601238 · Cited by 217
Riddick, A. C. P., Shukla, C. J., Pennington, C. J., Bass, R., Nuttall, R. K., Hogan, A., Sethia, K. K., Ellis, V, Collins, A. T., Maitland, N. J., et al. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602630 · Cited by 198
Morgia, G., Falsaperla, M., Malaponte, G., Madonia, M., Indelicato, M., Travali, S., & Mazzarino, M. C. (2005) · Urological Research · doi:10.1007/s00240-004-0440-8 · Cited by 190
Mañes, S., Llorente, M., Lacalle, R. A., Gómez-Moutón, C., Kremer, L., Mira, E., & Martı́nez-A, C. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.11.6935 · Cited by 188
Ree, A. H., Flørenes, V. A., Berg, J. P., Mælandsmo, G. M., Nesland, J. M., & Fodstad, Ø. (1997) · PubMed · Cited by 185
Jones, J. L., Glynn, P., & Walker, R. A. (1999) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199910)189:2<161::aid-path406>3.0.co;2-2 · Cited by 183
Li, H.-C., Cao, D.-C., Liu, Y., Hou, Y.-F., Wu, J., Lu, J.-S., Di, G.-H., Liu, G., Li, F.-M., Ou, Z.-L., et al. (2004) · Breast Cancer Research and Treatment · doi:10.1007/s10549-004-1200-8 · Cited by 181
Cathepsin B and tumor proteolysis: contribution of the tumor microenvironment
SLOANE, B., YAN, S., PODGORSKI, I., LINEBAUGH, B., CHER, M., MAI, J., CAVALLOMEDVED, D., SAMENI, M., DOSESCU, J., & MOIN, K. (2005) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2004.08.001 · Cited by 174
Wasenius, V.-M., Hemmer, S., Kettunen, E., Knuutila, S., Franssila, K., & Joensuu, H. (2003) · PubMed · Cited by 163
Cysteine cathepsins (proteases)—On the main stage of cancer?
Turk, V., Kos, J., & Turk, B. (2004) · Cancer Cell · doi:10.1016/s1535-6108(04)00117-5 · Cited by 161
Parker, R. L., Huntsman, D. G., Lesack, D. W., Cupples, J. B., Grant, D. R., Akbari, M., & Gilks, C. B. (2002) · American Journal of Clinical Pathology · doi:10.1309/pef8-gl6f-ywmc-ag56 · Cited by 161
Matrilysin [MMP-7] Expression Selects for Cells with Reduced Sensitivity to Apoptosis
Fingleton, B., Vargo-Gogola, T., Crawford, H. C., & Matrisian, L. M. (2001) · Neoplasia · doi:10.1038/sj.neo.7900190 · Cited by 158
Molecular pathology of prostate cancer
Hughes, C., Murphy, A., Martin, C., Sheils, O., & O’Leary, J. (2005) · Journal of Clinical Pathology · doi:10.1136/jcp.2002.003954 · Cited by 158
Yamashita, H., Nishio, M., Toyama, T., Sugiura, H., Zhang, Z., Kobayashi, S., & Iwase, H. (2003) · Breast Cancer Research · doi:10.1186/bcr738 · Cited by 152
Nielsen, B. S., Rank, F. E., López, J. M., Balbín, M., Vizoso, F. J., Lund, L. R., Danø, K., & López-Otín, C. (2001) · PubMed · Cited by 135
Self-citationGohji, K., Fujimoto, N., Hara, I., Fujii, A., Gotoh, A., Okada, H., Arakawa, S., Kitazawa, S., Miyake, H., Kamidono, S., et al. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19980220)79:1<96::aid-ijc18>3.0.co;2-f · Cited by 134
Significance of MMP-2 expression in prostate cancer: an immunohistochemical study.
Trudel, D., Fradet, Y., Meyer, F., Harel, F., & Têtu, B. (2003) · PubMed · Cited by 133
Boulay, A., Masson, R., Chenard, M., Fahime, E. E., Cassard, L., Bellocq, J., Sautès‐Fridman, C., Basset, P., & Rio, M. C. (2001) · PubMed · Cited by 127
Brehmer, B., Biesterfeld, S., & Jakse, G. (2003) · Prostate Cancer and Prostatic Diseases · doi:10.1038/sj.pcan.4500657 · Cited by 125
Schrohl, A., Holten-Andersen, M., Peters, H. A., Look, M. P., Gelder, M. E. M., Klijn, J. G. M., Brünner, N., & Foekens, J. A. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0360 · Cited by 125
Dong, Z., Bonfil, R. D., Chinni, S. R., Deng, X., Filho, J. C. T., Bernardo, M. M., Vaishampayan, U. N., Che, M., Sloane, B. F., Sheng, S., et al. (2005) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)62337-1 · Cited by 119
MMP-2 Protein in Invasive Breast Cancer and the Impact of MMP-2/TIMP-2 Phenotype on Overall Survival
Nakopoulou, L., Tsirmpa, I., Alexandrou, P. T., Louvrou, A., Ampela, C., Markaki, S. P., & Davaris, P. S. (2003) · Breast Cancer Research and Treatment · doi:10.1023/a:1021371028777 · Cited by 117
Tissue inhibitor of metalloproteinases-1 in breast cancer
Würtz, S. Ø., Schrohl, A.-S., Sørensen, N. M., Lademann, U., Christensen, I. J., Mouridsen, H., & Brünner, N. (2005) · Endocrine Related Cancer · doi:10.1677/erc.1.00719 · Cited by 115
Lack of lymphangiogenesis during breast carcinogenesis
Vleugel, M. M., Bos, R., van der Groep, P., Greijer, A. E., Shvarts, A., Stel, H. V., van der Wall, E., & van Diest, P. J. (2004) · Journal of Clinical Pathology · doi:10.1136/jcp.2003.014480 · Cited by 113
Cao, J. P., Chiarelli, C., Richman, O., Zarrabi, K. K., Kozarekar, P., & Zucker, S. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m705759200 · Cited by 107
Spurbeck, W. W., Ng, C. Y., Strom, T. S., Vanin, E. F., & Davidoff, A. M. (2002) · Blood · doi:10.1182/blood.v100.9.3361 · Cited by 101
Metastatin: a hyaluronan-binding complex from cartilage that inhibits tumor growth.
Liu, N., Lapcevich, R., Underhill, C. B., Han, Z., Gao, F., Swartz, G., Plum, S., Zhang, L., & Green, S. J. (2001) · PubMed · Cited by 100
Jiang, W. G., Davies, G., Martin, T. A., Parr, C., Watkins, G., Mason, M. D., Mokbel, K., & Mansel, R. E. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0275 · Cited by 95
González, L. O., Pidal, I., Junquera, S., Corte-Torres, M. D., Vázquez, J., Rodríguez, J. C., Lamelas, M. L., Merino, A. M., García-Muñiz, J. L., & Vizoso, F. J. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603963 · Cited by 91
Self-citationMatrix metalloproteinase-1 promotes prostate tumor growth and metastasis
Rao, J. S., & Pulukuri, S. M. K. (2008) · International Journal of Oncology · doi:10.3892/ijo.32.4.757 · Cited by 86
Prostate Cancer-Associated Membrane Type 1-Matrix Metalloproteinase
Bonfil, R. D., Dong, Z., Filho, J. C. T., Sabbota, A. L., Osenkowski, P., Nabha, S. M., Yamamoto, H., Chinni, S. R., Zhao, H., Mobashery, S., et al. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.060720 · Cited by 72
Wang, F., Reierstad, S., & Fishman, D. A. (2005) · Cancer Letters · doi:10.1016/j.canlet.2005.05.042 · Cited by 67
The fabric of cancer cell biology—Weaving together the strands
Klausner, R. D. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00020-x · Cited by 57
Daja, M. M., Niu, X. M., Zhao, Z., Brown, J. M., & Russell, P. J. (2003) · Prostate Cancer and Prostatic Diseases · doi:10.1038/sj.pcan.4500609 · Cited by 56
Span, P. N., Lindberg, R. L. P., Manders, P., Tjan‐Heijnen, V. C. G., Heuvel, J. J. T. M., Beex, L. V. A. M., & Sweep, F. C. G. J. (2004) · The Journal of Pathology · doi:10.1002/path.1528 · Cited by 56
Membrane type 1-matrix metalloproteinase promotes human prostate cancer invasion and metastasis
Chiarelli, C., Kozarekar, P., Adler, H. L., & Cao, J. P. (2005) · Thrombosis and Haemostasis · doi:10.1160/th04-08-0555 · Cited by 52
Prognostic relevance of uPAR-del4/5 and TIMP-3 mRNA expression levels in breast cancer
Kotzsch, M., Farthmann, J., Meye, A., Fuessel, S., Baretton, G., Tjan-Heijnen, V. C. G., Schmitt, M., Luther, T., Sweep, F. C. G. J., Magdolen, V., et al. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.09.002 · Cited by 50
New Roles for Matrix Metalloproteinases in Metastasis
Demers, M., Couillard, J., Belanger, S., & St‐Pierre, Y. (2005) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.v25.i6.30 · Cited by 35
Nabha, S. M., Bonfil, R. D., Yamamoto, H., Belizi, A., Wiesner, C., Dong, Z., & Cher, M. L. (2006) · Clinical & Experimental Metastasis · doi:10.1007/s10585-006-9042-x · Cited by 29
Regulation of matrix metalloproteinase 13 expression by androgen in prostate cancer
Pang, S., Flores‐Morales, A., Skoog, L. K., Chuan, Y.-C., Nordstedt, G., & Pousette, Å. (2004) · Oncology Reports · doi:10.3892/or.11.6.1187 · Cited by 28
Varani, J., Hattori, Y., Dame, M. K., Schmidt, T., Murphy, H. S., Johnson, K. J., & Wojno, K. J. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2000.1712 · Cited by 28
Cited by
Mesenchymal stem cell secretome: toward cell-free therapeutic strategies in regenerative medicine
Vizoso, F., Eiro, N., Cid, S., Schneider, J., & Perez-Fernandez, R. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18091852 · Cited by 1,363
“This is relevant because CAFs, a prevailing component of tumor stroma, contribute to tumor growth, invasion and dissemination [145,146].”
BackgroundSelf-citationMatrix Metalloproteinase Inhibitors in Cancer Therapy: Turning Past Failures Into Future Successes
Winer, A., Adams, S., & Mignatti, P. (2018) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-17-0646 · Cited by 651
Matrix Metalloproteinase-Induced Epithelial-Mesenchymal Transition in Breast Cancer
Radisky, E. S., & Radisky, D. C. (2010) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-010-9177-x · Cited by 524
Köhrmann, A., Kammerer, U., Kapp, M., Dietl, J., & Anacker, J. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-188 · Cited by 384
NF‐κB and epithelial to mesenchymal transition of cancer
Min, C., Eddy, S. F., Sherr, D. H., & Sonenshein, G. E. (2008) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21695 · Cited by 376
Metadata
- Authors
- Vizoso, F. J., González, L. O., Corte, M. D., Rodríguez, J. C., Vázquez, J., Lamelas, M. L., Junquera, S., Merino, A. M., & García-Muñiz, J. L.
- Venue
- British Journal of Cancer
- Published
- 2007-03
- Volume
- 96
- Issue
- 6
- Pages
- 903-911
- ISSN
- 0007-0920 (ISSN-L)
- 1532-1827
- OpenAlex
- W1998847259
- Cited by
- 271
- References
- 73
- FWCI
- 6.21
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.